Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome

Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome

Background: Little is known regarding the clinical impact of treatment and treatment duration of probiotic VSL#3 on gut and microbiome function in irritable bowel syndrome (IBS). As part of a safety trial, we assessed the effect of VSL#3 treatment duration on abdominal pain, stooling, gut permeabili...

Full description

Bibliographic Details
Main Authors: Prapaporn Boonma, Jordan M. Shapiro, Emily B. Hollister, Shyam Badu, Qinglong Wu, Erica M. Weidler, Bincy P. Abraham, Sridevi Devaraj, Ruth Ann Luna, James Versalovic, Margaret M. Heitkemper, Tor C. Savidge, Robert J. Shulman
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Pain Research
Subjects:
irritable bowel syndrome
VSL#3
probiotic
permeability
microbiome
bile acids
Online Access:https://www.frontiersin.org/articles/10.3389/fpain.2021.691689/full

Internet

https://www.frontiersin.org/articles/10.3389/fpain.2021.691689/full

Similar Items